Pharmacists Provide Telemedicine in Addition to Clinic Visits to Improve Diabetes Management

NCT02344082 | Completed

• 2 other identifiers: IRB000519471819
• Study Type: interventional
• Target: 30
• Locations: 0 countries
• Sites: N/A

Brief Summary

This prospective study will include both an intervention and control arm. The control arm will receive face-to-face pharmacy clinic visits per standard of care. The intervention arm will receive pharmacy clinic visits plus additional telephone follow-up. Patients with a hemoglobin A1c in the last 3 months greater than 9% will be eligible. Eligible patients must have a primary care physician at Johns Hopkins Outpatient Center (JHOC) or East Baltimore Medical Center (EBMC). Purpose: To compare the change in hemoglobin A1c over the 3 month study period in the intervention group in which patients participate in telemedicine, to a control group in which they do not

Conditions

Telemedicine

Outcome Measures

Primary Outcomes (1)

• Change in hemoglobin A1c

  A1c at 3 months - A1c at Baseline

  3 months

Secondary Outcomes (5)

• Patient adherence to office visits (# visits attended/# of visits scheduled)

  3 months

• Pharmacist interventions (Number of pharmacist interventions (lifestyle or medication changes) made)

  3 months

• Patient satisfaction (Based on survey results)

  3 months

• Telemedicine in Usual Care (Percent of patients who receive telephone call under usual care)

  3 months

• Telemedicine Adherence (Percent of telephone encounters completed in intervention arm)

  3 months

Study Arms (2)

Standard of Care

NO INTERVENTION

The control arm will receive face-to-face pharmacy clinic visits per usual care.

Intervention Arm

ACTIVE COMPARATOR

The intervention arm will receive pharmacy clinic visits plus additional telephone follow-up.

Other: Telemedicine

Interventions

Telemedicine OTHER

The intervention arm will receive pharmacy clinic visits plus additional telephone follow-up.

Intervention Arm

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Adult patients with a primary care provider at JHOC or EMBC
• Patients have seen primary care provider within last 6 months
• Patients with hemoglobin A1c greater than 9%

You may not qualify if:

• Patients \<18 years of age
• Patients with previously established care with JHH ambulatory care pharmacist
• Patients with communication barriers who do not have a caregiver
• Patients with new diagnosis of diabetes
• Patients who are pregnant or planning to become pregnant during the time of the study
• Patients followed by Endocrinology or Diabetes Center

Sponsors & Collaborators

• Johns Hopkins University: lead

MeSH Terms

Interventions

Telemedicine

Intervention Hierarchy (Ancestors)

Delivery of Health Care; Patient Care Management; Health Services Administration

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 8, 2015
• First Posted: January 22, 2015
• Study Start: January 1, 2015
• Primary Completion: June 1, 2015
• Study Completion: June 1, 2015
• Last Updated: December 20, 2018

Record last verified: 2018-12